U.S. health officials on Friday approved a closely watched Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.
U.S. approves Leqembi, a drug that modestly slows Alzheimer's
Post a Comment